These included reductions in functional and cardiovascular age, greater exercise tolerance, and notably lower mortality: treated individuals had 28% fewer deaths overall, about half the cardiovascular mortality, and reduced incidence of heart failure & respiratory disease compared to controls
This patient is seen here at 1 month after their lip repair, with a good lip and nose foundation for their long future ahead
This guide covers both
Triple Agonist Peptides Explained: Retatrutide, GLP-3, and the Future of Metabolic Research Durham Peptides Apr 23 8 min read Updated: 1 day ago Triple agonist peptides retatrutide GLP-3 research Durham Peptides Canada Few peptide categories have moved as fast as triple agonist metabolic peptides
[cited 2022 June 20]
Chen, W.F., Huang, S.Y., Liao, C.Y., Sung, C.S., Chen, J.Y., and Wen, Z.H., Biomaterials , 2015, vol